Tracking Tumour and Host Response in Cancer Using Multi-Modal Liquid Biopsy

Thursday, January 28, 2027 at 4:10 PM to 4:40 PM · 30 min. (Europe/London)
Cancer Diagnostics Stage
Day 2 - Thursday 28th January
CancerDiagnosticsLiquid BiopsyMulti-Omics

Information

  • Why the field is moving from single-modality assays towards multimodal liquid biopsy approaches. 
  • How genomics, epigenomics, fragmentomics and transcriptomics can be integrated to provide a more comprehensive minimally invasive view of cancer biology. 
  • The importance of analysing both tumour-derived and host-derived cell-free nucleic acids. 
  • Emerging applications of liquid biopsy beyond early detection and MRD, including immunotherapy monitoring and toxicity assessment. 
  • Future opportunities and challenges in translating multimodal liquid biopsy approaches into clinical practice.